AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34265462
Drug: mRNA BNT162b2
RxNorm normalized name: SARS-CoV-2 vaccine, mRNA BNT162b2 bivalent original & OMICRON (BA.4/.5) 0.3 ML Injection, 12y+ (EUA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mRNA BNT162b2 (1 dose)
Trial: 39461861
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol
Trial: 33606918
Drug: Acarbose 100
RxNorm normalized name: acarbose 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 100 mg
Trial: 616505834
Drug: Fibre-free nutrition
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibre-free nutrition solution
Trial: 33397443
Drug: LSI +
RxNorm normalized name: Lisdexamfetamine
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: LSI + pioglitazone (PGZ) 15 mg qd
Trial: 33220462
Drug: Bencycloquidium bromide
RxNorm normalized name: Potassium Bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bencycloquidium bromide (BCQB) 500 μg
Trial: 33220462
Drug: Bencycloquidium bromide
RxNorm normalized name: Potassium Bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bencycloquidium bromide (BCQB) 750 μg
Trial: 36282530
Drug: risankizumab 150
RxNorm normalized name: RISANKIZUMAB 150MG/ML ON-BODY KIT 2.4ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: risankizumab 150 mg
Trial: 32016386
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intravenous zoledronate at 5.5 years (PZ, n = 17)
Trial: 33565041
Drug: Intensive residential
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive residential treatment for OCD
Trial: 32044750
Drug: Knowledge Translation
RxNorm normalized name: CONNECTOR,ENFIT TRANSITIONAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge Translation (KT) intervention including weekly email alerts and social media engagement for 12 weeks
Trial: 33749643
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (0.8 mg/day)
Trial: 34324836
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination (1Dim group) - 5 × 10^10 viral particles
Trial: 34324836
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination (2Dim group) - 10 × 10^10 viral particles
Trial: 32818475
Drug: Multimodal physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal physical therapy
Trial: 32732587
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 4000 IU daily
Trial: 33601293
Drug: TMZ or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMZ or oral lomustine (CCNU) 110 mg/m2 (TMZ/CCNU)
Trial: 32513289
Drug: Ivermectin 400
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 400 μg/kg
Trial: 34932192
Drug: Novel drug
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel drug candidate for nocturnal polyuria
Trial: 35691565
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (OC) use
Trial: 38273597
Drug: Secukinumab 75
RxNorm normalized name: SECUKINUMAB 75MG/0.5ML INJ 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 75 mg
Trial: 36049698
Drug: Hand cream
RxNorm normalized name: TETRIX HAND CREAM,TOP
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand cream (control group)
Trial: 35167764
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (25,000 IU weekly)
Trial: 38695087
Drug: Subcutaneous ICD
RxNorm normalized name: ICDMT
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous ICD
Trial: 33081758
Drug: Continuing oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuing oxytocin infusion
Trial: 32051080
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine adjuvant therapy
Trial: 32201442
Drug: Methotrexate 7.5
RxNorm normalized name: methotrexate 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate 7.5 mg/week for 12 weeks
Trial: 32201442
Drug: Pioglitazone 15
RxNorm normalized name: pioglitazone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 15 mg tablets once daily for 12 weeks
Trial: 32061188
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug
Trial: 37173129
Drug: Natalizumab treatment
RxNorm normalized name: Natalizumab
DrugBank: Natalizumab (DB00108)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Natalizumab treatment
Trial: 35144924
Drug: Anifrolumab basic
RxNorm normalized name: anifrolumab
DrugBank: Anifrolumab (DB11976)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anifrolumab basic regimen (BR, 300 mg)
Trial: 34003409
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NCT)
Trial: 38253897
Drug: Cochlear Implant
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear Implant (CI)
Trial: 37903483
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg
Trial: 32023373
Drug: Traditional threshold
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional threshold treatment (glucose concentration <47 mg/dL)
Trial: 33055589
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with cisplatin and docetaxel, followed by concomitant chemoradiation therapy with cisplatin, docetaxel, and 45Gy, plus adjuvant cetuximab.
Trial: 32195934
Drug: Zopiclone 7.5
RxNorm normalized name: zopiclone 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 7.5 mg at bedtime
Trial: 36093886
Drug: PEEP of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEEP of 12 cmH2O with hourly ARMs (n=83)
Trial: 37705327
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (PPI)
Trial: 33156099
Drug: Engerix-B double
RxNorm normalized name: Engerix-B
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Engerix-B double dose
Trial: 32519208
Drug: Well-being under
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Well-being under treatment
Trial: 33176205
Drug: Typhoid Conjugate
RxNorm normalized name: Typhoid conjugate vaccine (TCV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhoid Conjugate Vaccine (TCV) plus control vaccine (inactivated polio vaccine) and MCV-A 28 days later
Trial: 39697147
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy
Trial: 39732701
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual (TAU)
Trial: 36305511
Drug: Scheduled acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled acetaminophen and as-needed opioids (Arm A)
Trial: 33234138
Drug: Estradiol therapy
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol therapy for women 15–49 years
Trial: 34858175
Drug: Red Ginseng
RxNorm normalized name: Red ginseng
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Ginseng (RG) - 3 g/d for 12 weeks
Trial: 33645253
Drug: Hyperglycemic clamp
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperglycemic clamp protocol with glucose targets of 200 mg/dL and >450 mg/dL, utilizing a centralized spreadsheet-based algorithm for dextrose infusion rates.
Trial: 34448273
Drug: TAC monotherapy
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TAC monotherapy (Tacrolimus only after tapering Mycophenolate mofetil)
Trial: 38837237
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (ESWT)
Trial: 35255530
Drug: Esketamine 0
RxNorm normalized name: ESKETAMINE
DrugBank: Esketamine (DB11823)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Esketamine 0 mg/kg
Trial: 35776028
Drug: Midazolam-based total
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam-based total intravenous anesthesia (TIVA)
Trial: 32703246
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 900 mg daily for 6 months
Trial: 32144522
Drug: Six doses
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Six doses of IV‐TXA combined with three doses of IV‐DXM (total dosage = 40 mg)
Trial: 32187170
Drug: Rectal positivity
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal positivity for GC
Trial: 32187170
Drug: Rectal positivity
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal positivity for CT
Trial: 33661918
Drug: Drug-eluting stent
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stent
Trial: 33544990
Drug: O-R toothbrush
RxNorm normalized name: OSTOMY SET,STERILE O.R.GUARDIAN H#4673
FDA approved: no
EMA approved: no
PMDA approved: no
Description: O-R toothbrush (Oral-B iO)
Trial: 35042948
Drug: Dextroamphetamine (d-amp)
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (d-amp) 10 or 20 mg
Trial: 32747497
Drug: BNP infusion
RxNorm normalized name: BNP
DrugBank: Nesiritide (DB04899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BNP infusion
Trial: 35307306
Drug: APPv treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APPv treatment
Trial: 36458325
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg (E14)
Trial: 33582692
Drug: Caudal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal block with 2 mg/kg Bupivacaine mixed with 0.75 mcg/kg Dexmedetomidine (Group B)
Trial: 32600336
Drug: Cooling therapy
RxNorm normalized name: MENTHOL 2.8 g in 56 g TOPICAL CREAM [elevate COOLING THERAPY TWIST UP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooling therapy initiated before reperfusion
Trial: 32703340
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose naltrexone 6mg daily
Trial: 35473439
Drug: Twice-daily dosing
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily dosing of deferasirox
Trial: 32303515
Drug: SAFE plus
RxNorm normalized name: ALCOHOL 350 mL in 500 mL TOPICAL GEL [WHITE CELEB SAFE PLUS Gel (ETHANOL)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAFE plus treatment‐as‐usual (TAU)
Trial: 36894879
Drug: Beta-blocker therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker therapy
Trial: 34151607
Drug: Inpatient isolation
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient isolation treatment for COVID-19 patients
Trial: 34250977
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration of CYD-TDV and quadrivalent HPV vaccine
Trial: 616739365
Drug: Sonidegib 200
RxNorm normalized name: sonidegib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonidegib 200 mg daily
Trial: 32541215
Drug: Direct oral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct oral feeding (DOF)
Trial: 32827412
Drug: NR-INF-02 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NR-INF-02 at 1000 mg for 84 days
Trial: 39548016
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg
Trial: 38300408
Drug: Guselkumab 100
RxNorm normalized name: guselkumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab 100 mg
Trial: 33009629
Drug: Etifoxine 150
RxNorm normalized name: etifoxine
DrugBank: Etifoxine (DB08986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etifoxine 150 mg/day for 12 weeks
Trial: 32669099
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA 1.5 g twice daily starting from 3 days before the operation)
Trial: 38468293
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy (CBT)
Trial: 34006388
Drug: Metformin (Met)
RxNorm normalized name: metformin / pioglitazone Oral Tablet [Actoplus Met]
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (Met) 500 mg tablets twice daily
Trial: 32578066
Drug: Steroid group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid group
Trial: 32825817
Drug: Goal-directed lactated
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed lactated Ringer's solution (crystalloid)
Trial: 33110042
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and Vitamin D (400 IU of 25-hydroxyvitamin-D and 1,000 mg of calcium per day)
Trial: 39082471
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockers (CCBs)
Trial: 33784280
Drug: Immediate oral
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate oral feeding (8 hours after management)
Trial: 33784280
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral feeding (48 hours after management)
Trial: 34586357
Drug: Pain Reprocessing
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain Reprocessing Therapy (PRT)
Trial: 34478173
Drug: NGT-G
RxNorm normalized name: Nitroglycerin
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NGT-G
Trial: 32006516
Drug: Monovalent varicella
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent varicella vaccine
Trial: 35701314
Drug: Comprehensive pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Comprehensive pharmaceutical care intervention added to cardiac rehabilitation program
Trial: 39186315
Drug: Rituximab therapy
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab therapy
Trial: 38746861
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide
Trial: 36271942
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor (enalapril)
Trial: 36084965
Drug: PolyMem dressing
RxNorm normalized name: Polymem Dressing 4x5"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PolyMem dressing (conventional treatment)
Trial: 35491539
Drug: Single and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single and multiple doses of Youkenafil Hydrochloride (up to 200 mg single dose and up to 150 mg multiple doses)
Trial: 35896462
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 1000 mg
Trial: 35030255
Drug: Sirolimus monotherapy
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus monotherapy
Trial: 34882589
Drug: CoronaVac vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoronaVac vaccine
Trial: 34910825
Drug: OFD+ABG+L-PRF
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OFD+ABG+L-PRF
Trial: 39038096
Drug: Best medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best medical treatment (BMT) alone
Trial: 32068688
Drug: NT-814 100
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NT-814 100 mg
Trial: 33734828
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atomoxetine + 5 mg solifenacin succinate (ato-sol)
Trial: 34538402
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with durvalumab 4-weekly for one year plus two doses of tremelimumab (CTLA-4 inhibitor) at day 1 of the first two 4-weekly cycles (Arm C)
Trial: 35651299
Drug: Clemastine fumarate
RxNorm normalized name: Clemastine Fumarate
DrugBank: Clemastine (DB00283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clemastine fumarate injection
Trial: 35344474
Drug: Online hypnotic
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Online hypnotic intervention for 7 weeks
Trial: 37103592
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT)
Trial: 32801167
Drug: Cladribine tablets
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine tablets (10 mg, cumulative dose 3.5 mg/kg over 2 years)
Trial: 33999753
Drug: Standard Tru-Cut
RxNorm normalized name: Tru-micin
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Tru-Cut needle (BARD 18 G)
Trial: 34705137
Drug: Early Botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early Botulinum toxin injection
Trial: 38625671
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg
Trial: 36284645
Drug: Favipiravir 1800
RxNorm normalized name: favipiravir
DrugBank: Favipiravir (DB12466)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Favipiravir 1800 mg on day 1, then 800 mg twice daily for 14 days
Trial: 37730405
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (control group)
Trial: 38015467
Drug: Lenalidomide 25
RxNorm normalized name: lenalidomide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 25 mg
Trial: 33567780
Drug: Spirulina maxima
RxNorm normalized name: SPIRULINA MAXIMA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirulina maxima intake (5 g/day) + Exercise program
Trial: 34726026
Drug: Classic rehabilitation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classic rehabilitation training, performed twice a week for 12 weeks.
Trial: 35274222
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg warfarin
Trial: 33513645
Drug: Testosterone replacement
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone replacement therapy
Trial: 33878154
Drug: Golimumab (GLM)
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Golimumab (GLM) 50 mg every 4 weeks during the OLE